Background and Purpose-Perfusion imaging has the potential to select patients most likely to respond to thrombolysis.
A mismatch between the irreversibly damaged infarct core and the extent of hypoperfused tissue at risk for infarction is an attractive paradigm with which to select ischemic stroke patients for reperfusion therapies. 1, 2 There has been intense investigation into magnetic resonance imaging (MRI) perfusion-diffusion mismatch over the past decade with refined criteria now being tested in large clinical trials. Diffusion imaging has been established as an accurate representation of irreversible infarction, [3] [4] [5] and Tmax Ͼ5 to 6 seconds has been demonstrated as the best predictor of tissue destined for infarction in the absence of reperfusion. 6 -8 A meta-analysis of randomized trials that used mismatch selection has demonstrated that reperfusion was associated with favorable clinical outcome in patients with mismatch. 9 Computed tomography perfusion (CTP) also has the potential to identify "mismatch" indicating salvageable brain tissue and has advantages over MRI in accessibility and speed in the emergency department setting. However, there has been limited validation of CTP parameters against the more extensively studied MRI perfusion-diffusion mismatch paradigm. 10 Recent evidence has emerged that relative cerebral blood flow (relCBF) performs better than other parameters, including cerebral blood volume (CBV), in predicting the infarct core indicated by concurrent diffusion imaging. [11] [12] [13] However, "false-positive" low CBF regions in white matter, particularly in regions of leukoaraiosis, were noted to be problematic. We tested the effect of restricting the core to voxels with both low relCBF and delayed time to peak (TTP) to reduce these white matter false-positive lesions. We then assessed the correspondence of CTP Tmax hypoperfusion to the threshold of MR Tmax Ͼ6 seconds. Using these optimized CTP core and penumbra definitions, we proceeded to analyze the diagnostic accuracy of CTP mismatch classification with contemporaneous perfusion-diffusion MRI mismatch.
Patients and Methods

Patients
Consecutive acute ischemic stroke patients presenting within 6 hours of stroke onset at a single center had diffusion and perfusion MRI (1.5-T Siemens Magnetom Vision) obtained Ͻ1 hour after CTP as part of a prospective observational study and as previously published. 11, 12 The patients were all participants in trials requiring perfusion-diffusion MRI for entry at a time when the accepted time window for thrombolysis was 0 to 3 hours. CT perfusion therefore could be obtained while awaiting MRI without delaying treatment. Eligibility criteria were symptoms of acute hemispheric stroke, absence of hemorrhage, or established infarction of more than one-third of the middle cerebral artery territory on noncontrast CT and absence of contraindication to CT or magnetic resonance (MR) with contrast agents. Both imaging modalities were acquired before any thrombolysis. The study was approved by the institutional ethics committee. All patients gave written informed consent. Patients were included in this analysis if at least 1 CT perfusion slab contained abnormal CT or coregistered MR perfusion and/or a component of the coregistered diffusion lesion. Patients were excluded if the contrast bolus arrived before the commencement of the acquisition or did not give rise to a detectable arterial input function. CT and MR angiography data were reviewed by 2 independent stroke neurologists (B.C. with Ͼ5 years of experience and M.P. with Ͼ10 years of experience) to identify any cases of spontaneous recanalization between CT and MR imaging.
CT Acquisition
Two separate CTP slabs, each 24 mm thick, were acquired consecutively (16-slice Phillips Mx8000 scanner) and positioned to maximize supratentorial coverage. Iodinated contrast (40 mL) was injected at 5 mL/s and 35 images were acquired every 1.3 seconds (total acquisition time, 45 seconds). Each slab was formatted as 2ϫ12-mm slices.
CTP Analysis
Because commercial image processing software packages use a variety of postprocessing techniques that are often incompletely specified and usually not customizable, we developed our own image processing pipeline using open-source MINC tools (Montreal Neurological Institute) and in-house developed Matlab scripts (R2009b; Mathworks, Natick, MA). Automated motion correction (in-plane) was performed and the raw CTP data were down-sampled (bicubic without antialiasing) from 512ϫ512 to 256ϫ256. Gaussian smoothing was applied to the raw data (kernel width from 6 pixels [5.5-mm radius]). All nonbrain tissue voxels were excluded from the kernel weighting to avoid edge smearing. An arterial input function was selected from the anterior cerebral artery 14 and venous outflow function from the superior sagittal sinus by a user-supervised (B.C.) arterial input function detection algorithm. 15 Singular value decomposition deconvolution was performed with a standard (sSVD, delay-sensitive) algorithm to create maps of CBF and TTP of the tissue residue function (Tmax). Our previous work suggested that block circulant (delay-insensitive) deconvolution did not improve accuracy. 12 CBV and TTP were calculated from the concentrationtime curve. CBV and CBF were calculated relative (by ratio) to the mean of the entire contralateral hemisphere. TTP was expressed relative (by offset) to the mean of the entire contralateral hemisphere.
MRI Reference Standard
The perfusion and diffusion MRI were registered to each CTP slab using the noncontrast CT as an intermediary (MINC tools) and visually verified for accuracy using interactive image blending (B.C.). The maximal visual extent of the coregistered diffusion lesion was manually outlined (B.C.) and formed the reference standard for infarct core. 4 These manual regions of interest (ROI) were drawn without reference to other imaging over a 1-week period and independently verified by a second stroke neurologist (M.P.), with disagreements resolved by consensus. The B1000 image was used as the primary template because quantitative ADC thresholds tend to not accurately outline the visually evident lesion and they have been shown to vary with time after stroke onset and perfusion status. 16 The MRI perfusion maps were generated using the same methodology as CTP.
Infarct Core Optimization
This analysis was performed using the summed volumes from 2 separate CT slabs for each patient. A relCBF Ͻ31% of the contralateral mean was identified as the optimal threshold to define irreversible infarction in our previous work using this software. 12 Note that although relCBF was the most accurate CTP measure of infarct core, different processing pipelines may require a different threshold. In our previous work, we noted some inaccuracies because of "falsepositive" low CBF in white matter, especially in regions of leukoaraiosis. To reduce the false-positive contribution from white matter, we explored the effect of restricting relCBF core to regions of significant perfusion delay indicated by relTTP Ͼ4 seconds, which visually achieved exclusion of the white matter regions with no significant influence on the ROI over the actual lesion. Furthermore, relTTP ϽϪ4 seconds (ie, nonphysiological "early" bolus arrival) was included to encompass regions of very low CBV (essentially undetectable flow), where the concentration-time curve comprises only noise and TTP therefore becomes randomly distributed throughout the acquisition duration. The relTTP ROI was automatically thresholded and then postprocessed to remove small, isolated regions of false-positive voxels caused by noise. First, isolated regions with Ͻ5 mL volume were removed. Morphological opening and closure were then performed to remove edge artifacts and to fill-in residual small regions of low TTP within the perfusion lesion in areas of very low CBV. This relTTP-based ROI provided a more accurate outline of the perfusion lesion than a Tmax-based method because more of the low CBV regions tended to have Tmax of 0 and therefore were indistinguishable from normal brain.
Comparison of CT and MR Tmax
Receiver-operating characteristic analysis was performed to determine the optimal threshold (by Youden index 17 ) of CT-Tmax to match the coregistered concurrent MR-Tmax Ͼ6-second lesion as the reference standard following previously published methods 12, 18 within an ipsilateral hemisphere reference region. Confidence intervals for the global area under the curve statistics were derived by patient-level bootstrapping (10 000 random samples with replacement). Volumetric agreement with MR-Tmax Ͼ6 seconds was then assessed (Bland-Altman) at the receiver-operating characteristicderived optimal threshold using the summed volumes from 2 separate CT slabs for each patient.
Mismatch Analysis
Mismatch was defined using the MR criteria used for the EXTEND trial, 19 ie, a perfusion lesion-to-infarct core ratio Ͼ1.2, a perfusion lesion-infarct core volume Ͼ10 mL, and an infarct core volume Ͻ70 mL. These criteria were based on subgroup analysis of tissue plasminogen activator response in the EPITHET trial 20 and data indicating poor response to reperfusion in patients with large infarct core. 21, 22 A more stringent mismatch definition using mismatch ratio Ͼ1.8 23 as used in the DEFUSE-2 trial (NCT01349946) also was tested. The volumes of Tmax Ͼ6 seconds on MR and CT, the diffusion lesion on MR, and the TTP-constrained relCBF lesion on CT were calculated from the sum of 2 coregistered slabs per patient. Mismatch status using the original whole-brain perfusion and diffusion MR images was also calculated. Concordance between MR and CT mismatch was assessed using raw agreement and kappa.
Results
The 
Optimization of relCBF Infarct Core Identification
Volumetric agreement with the diffusion lesion was substantially improved by constraining relCBF Ͻ31% within the automated TTP perfusion lesion ROI (median magnitude of volume difference 15.8 mL vs unconstrained 47.5 mL;
PϽ0.001).
The magnitude of volume difference as a proportion of DWI volume reduced from a median 219% to 38% (PϽ0.001). The bias (average difference DWIϪCT-CBF) was reduced from Ϫ50 mL to Ϫ11.3 mL; in other words, with TTP-restriction, on average, CT-CBF core was still 11 mL larger than the corresponding diffusion lesion. Visual inspection demonstrated reduction of false-positive regions in white matter (Figure 2) . The Bland-Altman 95% limits of agreement were Ϫ46.9 and 24.2 mL (Figure 3A, B) .
CT vs MR Tmax
Receiver-operating characteristic analysis demonstrated the best CT-Tmax threshold to match MR-Tmax of Ͼ6 seconds was 6.2 seconds (95% confidence interval, 5.6 -7.3 seconds; sensitivity, 91%; specificity, 70%; area under the curve, 0.87). Because 6.2 seconds was not significantly different to 6.0 seconds, and because Tmax is generally calculated in 1-or 2-second increments because of the timing between each image acquisition, 6.0 seconds was used as the threshold for further analyses. The median magnitude of volume difference between the 2 coregistered CT and MR slabs using a Tmax threshold of Ͼ6 seconds was 18.4 mL (28%). The BlandAltman 95% limits of agreement were Ϫ41.1 and 56.9 mL ( Figure 3C ).
Mismatch Agreement
Mismatch agreement was initially tested using CT slabs and coregistered MRI diffusion and perfusion imaging to remove any effect of reduced brain coverage with CT. Using a CT-Tmax of Ͼ6 seconds "penumbra" and a relCBF of Ͻ31% (restricted to TTP Ͼ4 seconds) "core," CT-based and MRIbased mismatch status was concordant in 44 of 49 (90%) of patients. Kappa was 0.80, indicating excellent agreement. There were 2 false-positive results and 3 false-negative No diffusion or CT/MR perfusion lesion within slab coverage, n=7
Only one slab available, n=2
Spontaneous partial reperfusion between CT and MR, n=2
Inadequate contrast bolus, n=2
Excessive motion, n=1
Missing MR perfusion data, n=1
Eligible for analysis n=49
CTP Mismatch n=23
No CTP Mismatch n=26
MRI Mismatch n=21
No MRI Mismatch n=2
MRI Mismatch n=3
No MRI Mismatch n=23
MRI
Acute ischemic stroke patients imaged with CT and MRI, n=64 results. Sensitivity for mismatch was 88% and specificity was 92%. Positive predictive value was 91% and negative predictive value was 88%. With an alternative definition of mismatch using a mismatch ratio Ͼ1.8, agreement was similar (45/49; 92%; kappaϭ0.83). Because of the reduced brain coverage with 16-slice CTP, mismatch agreement between CTP and the whole-brain MRI was reduced to 39 of 49 (80%; kappaϭ0.59) or 40 of 49 (82%; kappaϭ0.63) using mismatch ratio Ͼ1.8. The discrepancies attributable to brain coverage were a combination of false-negative CT mismatch in 6 patients (because of unrecognized peripheral Tmax Ͼ6 seconds) and false-positive CT mismatch in 4 patients (infarct core was Ͼ70 mL when whole brain was assessed).
Discussion
This study has demonstrated that quantitative CTP mismatch classification using relCBF and Tmax is similar to perfusiondiffusion MRI. The identification of infarct core using rel-CBF can be significantly improved by simply restricting core to voxels with both low relCBF and delayed TTP. The MR-Tmax threshold of Ͼ6 seconds for salvageable hypoperfusion translates directly to CTP. The lower agreement of CTP with whole-brain MRI indicates the potential value of newer CT scanners with whole-brain coverage.
The problem of false-positive low CBF in white matter arises for 2 main reasons. The first is the well-recognized reduction in CBF in regions of leukoaraiosis. 24, 25 The second is the relatively low contrast-to-noise ratio of CTP compared with MRI and the physiological gradient in CBF between gray and white matter. 26 -29 This makes a good-quality acquisition, with adequate contrast bolus and slice thickness, essential to distinguish normal and abnormal white matter. To reduce the impact of low CBF in normal white matter and leukoaraiosis on mismatch classification, we restricted rel-CBF core to a relTTP lesion ROI to exclude regions outside the hypoperfused infarct. The TTP also may be delayed in leukoaraiosis, but the postprocessing to remove small isolated regions accounted for much of this. Despite good mismatch agreement, more sophisticated postprocessing should be actively investigated to improve the modest volumetric accuracy in this study, particularly for infarct core delineation. This is particularly relevant if measures such as infarct growth between baseline CTP and follow-up MRI are to be used.
A limitation of the CT data utilized in this study was the restricted brain coverage (5 cm), which lead to reduced mismatch agreement with whole-brain MRI compared with the within-slab CT-MR comparison. However, given the increasing use of modern CT scanners with whole-brain coverage, this limitation of CT is rapidly receding. The acquisition duration also was relatively brief, which may have led to bolus truncation in some patients. Although this did not affect the optimal relCBF threshold for core in our previous work, 12 our current practice is to use a longer acquisition. We chose a volumetric rather than voxel-based analysis. Coregistration of MRI data to the limited coverage CTP slabs introduces potential for error in volumetric calculations, but this effect would be magnified in a voxel-based analysis. Additionally, some variation in perfusion maps would be expected between 2 MRI perfusion acquisitions taken after separate contrast injections 30 minutes apart. Therefore, the magnitude of difference between CT and MR is probably not entirely attributable to technical variation between the 2 techniques. We believe agreement of Ϸ90% at the mismatch decision-making level is acceptable in this context. Although randomized order of CT and MRI would have been ideal, this would not have been possible without incurring treatment delay. Because the optimal threshold for infarct core utilized in this analysis was derived from within the same dataset, 12 further studies in independent datasets are warranted to confirm the wider applicability of this threshold.
The precision of MRI perfusion-diffusion imaging, particularly in accurately identifying infarct core, may remain superior to CTP. However, there is often restricted access to urgent MRI and contraindications (eg, uncharacterized metallic foreign bodies) create difficulties in the emergency setting. We have demonstrated that CTP can provide information similar to MRI at the level of treatment decisionmaking. Although there may be individual cases in which uncertainty about treatment benefit persists after CTP and in which addition of MRI would be justified, we believe a treatment decision could be made for the majority of patients on the basis of CTP alone. Therefore, CTP may allow more widespread application of the "mismatch" paradigm in clinical practice and trials. 
